메뉴 건너뛰기




Volumn 58, Issue 1, 2012, Pages 127-138

Emerging biomarkers in heart failure

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADRENOMEDULLIN; AMINO ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ARGIPRESSIN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CA 125 ANTIGEN; CALGRANULIN A; CALGRANULIN B; GALECTIN 3; GROWTH DIFFERENTIATION FACTOR 15; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; MIDKINE; MYELOPEROXIDASE; NATRIURETIC FACTOR; NEUROHORMONE; OSTEOPROTEGERIN; PENTRAXIN 3; SERINE PROTEINASE; TROPONIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UROCORTIN I;

EID: 84856071476     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.165720     Document Type: Review
Times cited : (223)

References (88)
  • 2
    • 33847327365 scopus 로고    scopus 로고
    • Benchmarks for the assessment of novel cardiovascular biomarkers
    • DOI 10.1161/CIRCULATIONAHA.106.683110, PII 0000301720070227000004
    • Morrow DA, de Lemos JA. Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation 2007;115:949-52. (Pubitemid 46328287)
    • (2007) Circulation , vol.115 , Issue.8 , pp. 949-952
    • Morrow, D.A.1    De Lemos, J.A.2
  • 3
    • 34548394664 scopus 로고    scopus 로고
    • National Academy of Clinical Biochemistry laboratory medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure
    • Tang WH, Francis GS, Morrow DA, Newby LK, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Circulation 2007;116:e99-109.
    • (2007) Circulation , vol.116
    • Tang, W.H.1    Francis, G.S.2    Morrow, D.A.3    Newby, L.K.4    Cannon, C.P.5    Jesse, R.L.6
  • 4
    • 79953035510 scopus 로고    scopus 로고
    • Evaluating the clinical utility of a biomarker: A review of methods for estimating health impact
    • Pletcher MJ, Pignone M. Evaluating the clinical utility of a biomarker: a review of methods for estimating health impact. Circulation 2011;123:1116-24.
    • (2011) Circulation , vol.123 , pp. 1116-1124
    • Pletcher, M.J.1    Pignone, M.2
  • 5
    • 43549099569 scopus 로고    scopus 로고
    • Biomarkers in heart failure
    • Braunwald E. Biomarkers in heart failure. N Engl J Med 2008;358:2148-59.
    • (2008) N Engl J Med , vol.358 , pp. 2148-2159
    • Braunwald, E.1
  • 6
    • 79960786335 scopus 로고    scopus 로고
    • Risk stratification and short-term prognosis in acute heart failure syndromes: A review of novel biomarkers
    • Avellino A, Collins SP, Fermann GJ. Risk stratification and short-term prognosis in acute heart failure syndromes: A review of novel biomarkers. Biomarkers. 2011;16:379-92.
    • (2011) Biomarkers , vol.16 , pp. 379-392
    • Avellino, A.1    Collins, S.P.2    Fermann, G.J.3
  • 8
    • 67349125810 scopus 로고    scopus 로고
    • The evolution of the natriuretic peptides: Current applications in human and animal medicine
    • van Kimmenade RR, Januzzi JL Jr. The evolution of the natriuretic peptides: current applications in human and animal medicine. J Vet Cardiol. 2009;11(Suppl 1):S9-21.
    • (2009) J Vet Cardiol , vol.11 , Issue.SUPPL. 1
    • Van Kimmenade, R.R.1    Januzzi Jr., J.L.2
  • 9
    • 79952661776 scopus 로고    scopus 로고
    • Pro-B-type natriuretic peptide(1-108) circulates in the general community: Plasma determinants and detection of left ventricular dysfunction
    • Macheret F, Boerrigter G, McKie P, Costello-Boerrigter L, Lahr B, Heublein D, et al. Pro-B-type natriuretic peptide(1-108) circulates in the general community: plasma determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 2011;57:1386-95.
    • (2011) J Am Coll Cardiol , vol.57 , pp. 1386-1395
    • Macheret, F.1    Boerrigter, G.2    McKie, P.3    Costello-Boerrigter, L.4    Lahr, B.5    Heublein, D.6
  • 10
    • 79955773505 scopus 로고    scopus 로고
    • Natriuretic peptide testing in heart failure
    • Kim HN, Januzzi JL Jr. Natriuretic peptide testing in heart failure. Circulation 2011;123:2015-9.
    • (2011) Circulation , vol.123 , pp. 2015-2019
    • Kim, H.N.1    Januzzi Jr., J.L.2
  • 11
    • 73449123365 scopus 로고    scopus 로고
    • B-type natriuretic peptides and cardiovascular risk: Systematic review and meta-analysis of 40 prospective studies
    • Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D, et al. B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation 2009;120:2177-87.
    • (2009) Circulation , vol.120 , pp. 2177-2187
    • Di Angelantonio, E.1    Chowdhury, R.2    Sarwar, N.3    Ray, K.K.4    Gobin, R.5    Saleheen, D.6
  • 12
    • 0034176934 scopus 로고    scopus 로고
    • Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
    • Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000;355:1126-30. (Pubitemid 30172933)
    • (2000) Lancet , vol.355 , Issue.9210 , pp. 1126-1130
    • Troughton, R.W.1    Frampton, C.M.2    Yandle, T.G.3    Espiner, E.A.4    Nicholls, M.G.5    Richards, A.M.6
  • 13
    • 78649983509 scopus 로고    scopus 로고
    • Biomarker-guided treatment of heart failure: Still waiting for a definitive answer
    • Troughton RW, Frampton CM, Nicholls MG. Biomarker-guided treatment of heart failure: still waiting for a definitive answer. J Am Coll Cardiol 2010;56:2101-4.
    • (2010) J Am Coll Cardiol , vol.56 , pp. 2101-2104
    • Troughton, R.W.1    Frampton, C.M.2    Nicholls, M.G.3
  • 14
    • 76449120415 scopus 로고    scopus 로고
    • N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study
    • Berger R, Moertl D, Peter S, Ahmadi R, Huelsmann M, Yamuti S, et al. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study. J Am Coll Cardiol 2010;55:645-53.
    • (2010) J Am Coll Cardiol , vol.55 , pp. 645-653
    • Berger, R.1    Moertl, D.2    Peter, S.3    Ahmadi, R.4    Huelsmann, M.5    Yamuti, S.6
  • 15
    • 77951646726 scopus 로고    scopus 로고
    • Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: Results from the BACH (Biomarkers in Acute Heart Failure) trial
    • Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, et al. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 2010;55:2062-76.
    • (2010) J Am Coll Cardiol , vol.55 , pp. 2062-2076
    • Maisel, A.1    Mueller, C.2    Nowak, R.3    Peacock, W.F.4    Landsberg, J.W.5    Ponikowski, P.6
  • 16
    • 0037432179 scopus 로고    scopus 로고
    • Identification of serum soluble ST2 receptor as a novel heart failure biomarker
    • DOI 10.1161/01.CIR.0000047274.66749.FE
    • Weinberg EO, Shimpo M, Hurwitz S, Tominaga S, Rouleau JL, Lee RT. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 2003;107:721-6. (Pubitemid 36222600)
    • (2003) Circulation , vol.107 , Issue.5 , pp. 721-726
    • Weinberg, E.O.1    Shimpo, M.2    Hurwitz, S.3    Tominaga, S.-I.4    Rouleau, J.-L.5    Lee, R.T.6
  • 17
    • 77949264462 scopus 로고    scopus 로고
    • Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling
    • Seki K, Sanada S, Kudinova AY, Steinhauser ML, Handa V, Gannon J, et al. Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling. Circ Heart Fail 2009;2:684-91.
    • (2009) Circ Heart Fail , vol.2 , pp. 684-691
    • Seki, K.1    Sanada, S.2    Kudinova, A.Y.3    Steinhauser, M.L.4    Handa, V.5    Gannon, J.6
  • 18
    • 53249113212 scopus 로고    scopus 로고
    • The IL-33/ST2 pathway: Therapeutic target and novel biomarker
    • Kakkar R, Lee RT. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 2008;7:827-40.
    • (2008) Nat Rev Drug Discov , vol.7 , pp. 827-840
    • Kakkar, R.1    Lee, R.T.2
  • 20
    • 73549108878 scopus 로고    scopus 로고
    • Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea
    • Shah RV, Chen-Tournoux AA, Picard MH, van Kimmenade RR, Januzzi JL. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea. Circ Heart Fail 2009;2:311-9.
    • (2009) Circ Heart Fail , vol.2 , pp. 311-319
    • Shah, R.V.1    Chen-Tournoux, A.A.2    Picard, M.H.3    Van Kimmenade, R.R.4    Januzzi, J.L.5
  • 21
    • 79960026972 scopus 로고    scopus 로고
    • Soluble ST2, high-sensitivity troponin T-and N-terminal pro-B-type natriuretic peptide: Complementary role for risk stratification in acutely decompensated heart failure
    • Pascual-Figal DA, Manzano-Fernandez S, Boronat M, Casas T, Garrido IP, Bonaque JC, et al. Soluble ST2, high-sensitivity troponin T-and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure. Eur J Heart Fail 2011;13:718-25.
    • (2011) Eur J Heart Fail , vol.13 , pp. 718-725
    • Pascual-Figal, D.A.1    Manzano-Fernandez, S.2    Boronat, M.3    Casas, T.4    Garrido, I.P.5    Bonaque, J.C.6
  • 22
    • 78649291119 scopus 로고    scopus 로고
    • Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure
    • Bayes-Genis A, Pascual-Figal D, Januzzi JL, Maisel A, Casas T, Valdes Chavarri M, et al. Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure. Rev Esp Cardiol 2010;63:1171-8.
    • (2010) Rev Esp Cardiol , vol.63 , pp. 1171-1178
    • Bayes-Genis, A.1    Pascual-Figal, D.2    Januzzi, J.L.3    Maisel, A.4    Casas, T.5    Valdes Chavarri, M.6
  • 23
    • 70349813786 scopus 로고    scopus 로고
    • Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma - The Presage ST2 assay
    • Dieplinger B, Januzzi JL Jr, Steinmair M, Gabriel C, Poelz W, Haltmayer M, et al. Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma - the Presage ST2 assay. Clin Chim Acta 2009;409:33-40.
    • (2009) Clin Chim Acta , vol.409 , pp. 33-40
    • Dieplinger, B.1    Januzzi Jr., J.L.2    Steinmair, M.3    Gabriel, C.4    Poelz, W.5    Haltmayer, M.6
  • 24
    • 33646076691 scopus 로고    scopus 로고
    • The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury
    • Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, Tongers J, et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res 2006;98:351-60.
    • (2006) Circ Res , vol.98 , pp. 351-360
    • Kempf, T.1    Eden, M.2    Strelau, J.3    Naguib, M.4    Willenbockel, C.5    Tongers, J.6
  • 25
    • 77958507769 scopus 로고    scopus 로고
    • Serial measurement of growth-differentiation factor-15 in heart failure: Relation to disease severity and prognosis in the Valsartan Heart Failure Trial
    • Anand IS, Kempf T, Rector TS, Tapken H, Allhoff T, Jantzen F, et al. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial. Circulation 2010;122:1387-95.
    • (2010) Circulation , vol.122 , pp. 1387-1395
    • Anand, I.S.1    Kempf, T.2    Rector, T.S.3    Tapken, H.4    Allhoff, T.5    Jantzen, F.6
  • 26
    • 8644230017 scopus 로고    scopus 로고
    • Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions
    • DOI 10.1007/s00441-004-0986-3
    • Schlittenhardt D, Schober A, Strelau J, Bonaterra GA, Schmiedt W, Unsicker K, et al. Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions. Cell Tissue Res 2004;318:325-33. (Pubitemid 39506502)
    • (2004) Cell and Tissue Research , vol.318 , Issue.2 , pp. 325-333
    • Schlittenhardt, D.1    Schober, A.2    Strelau, J.3    Bonaterra, G.A.4    Schmiedt, W.5    Unsicker, K.6    Metz, J.7    Kinscherf, R.8
  • 28
    • 70349983577 scopus 로고    scopus 로고
    • Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure
    • Miller WL, Hartman KA, Burritt MF, Grill DE, Jaffe AS. Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure. J Am Coll Cardiol 2009;54:1715-21.
    • (2009) J Am Coll Cardiol , vol.54 , pp. 1715-1721
    • Miller, W.L.1    Hartman, K.A.2    Burritt, M.F.3    Grill, D.E.4    Jaffe, A.S.5
  • 30
    • 71849117655 scopus 로고    scopus 로고
    • Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure
    • Tsutamoto T, Kawahara C, Nishiyama K, Yamaji M, Fujii M, Yamamoto T, et al. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure. Am Heart J 2010;159:63-7.
    • (2010) Am Heart J , vol.159 , pp. 63-67
    • Tsutamoto, T.1    Kawahara, C.2    Nishiyama, K.3    Yamaji, M.4    Fujii, M.5    Yamamoto, T.6
  • 31
    • 79960024453 scopus 로고    scopus 로고
    • Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure
    • Tentzeris I, Jarai R, Farhan S, Perkmann T, Schwarz MA, Jakl G, et al. Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure. Eur J Heart Fail 2011;13:726-33.
    • (2011) Eur J Heart Fail , vol.13 , pp. 726-733
    • Tentzeris, I.1    Jarai, R.2    Farhan, S.3    Perkmann, T.4    Schwarz, M.A.5    Jakl, G.6
  • 32
    • 78650400736 scopus 로고    scopus 로고
    • Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure
    • Xue Y, Clopton P, Peacock WF, Maisel AS. Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure. Eur J Heart Fail 2011;13:37-42.
    • (2011) Eur J Heart Fail , vol.13 , pp. 37-42
    • Xue, Y.1    Clopton, P.2    Peacock, W.F.3    Maisel, A.S.4
  • 33
    • 11244355392 scopus 로고
    • A study of C-reactive protein in the serum of patients with congestive heart failure
    • Elster SK, Braunwald E, Wood HF. A study of C-reactive protein in the serum of patients with congestive heart failure. Am Heart J 1956;51:533-41.
    • (1956) Am Heart J , vol.51 , pp. 533-541
    • Elster, S.K.1    Braunwald, E.2    Wood, H.F.3
  • 34
    • 79851486666 scopus 로고    scopus 로고
    • Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction
    • Matsubara J, Sugiyama S, Nozaki T, Sugamura K, Konishi M, Ohba K, et al. Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction. J Am Coll Cardiol 2011;57:861-9.
    • (2011) J Am Coll Cardiol , vol.57 , pp. 861-869
    • Matsubara, J.1    Sugiyama, S.2    Nozaki, T.3    Sugamura, K.4    Konishi, M.5    Ohba, K.6
  • 35
    • 77951639762 scopus 로고    scopus 로고
    • Inflammatory markers and incident heart failure risk in older adults: The Health ABC (Health, Aging, and Body Composition) study
    • Kalogeropoulos A, Georgiopoulou V, Psaty BM, Rodondi N, Smith AL, Harrison DG, et al. Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol 2010;55:2129-37.
    • (2010) J Am Coll Cardiol , vol.55 , pp. 2129-2137
    • Kalogeropoulos, A.1    Georgiopoulou, V.2    Psaty, B.M.3    Rodondi, N.4    Smith, A.L.5    Harrison, D.G.6
  • 36
    • 36849086574 scopus 로고    scopus 로고
    • Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure
    • DOI 10.1016/j.ahj.2007.08.013, PII S0002870307006886
    • Suzuki S, Takeishi Y, Niizeki T, Koyama Y, Kitahara T, Sasaki T, et al. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Am Heart J 2008;155:75-81. (Pubitemid 350234768)
    • (2008) American Heart Journal , vol.155 , Issue.1 , pp. 75-81
    • Suzuki, S.1    Takeishi, Y.2    Niizeki, T.3    Koyama, Y.4    Kitahara, T.5    Sasaki, T.6    Sagara, M.7    Kubota, I.8
  • 40
    • 0035942264 scopus 로고    scopus 로고
    • Cytokines and cytokine receptors in advanced heart failure: An analysis of the cytokine database from the Vesnarinone Trial (VEST)
    • Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001;103:2055-9. (Pubitemid 32373007)
    • (2001) Circulation , vol.103 , Issue.16 , pp. 2055-2059
    • Deswal, A.1    Petersen, N.J.2    Feldman, A.M.3    Young, J.B.4    White, B.G.5    Mann, D.L.6
  • 43
    • 40749084822 scopus 로고    scopus 로고
    • Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction
    • Salio M, Chimenti S, De Angelis N, Molla F, Maina V, Nebuloni M, et al. Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2008;117:1055-64.
    • (2008) Circulation , vol.117 , pp. 1055-1064
    • Salio, M.1    Chimenti, S.2    De Angelis, N.3    Molla, F.4    Maina, V.5    Nebuloni, M.6
  • 45
    • 65249159202 scopus 로고    scopus 로고
    • Usefulness of myeloperoxidase levels in healthy elderly subjects to predict risk of developing heart failure
    • Tang WH, Katz R, Brennan ML, Aviles RJ, Tracy RP, Psaty BM, et al. Usefulness of myeloperoxidase levels in healthy elderly subjects to predict risk of developing heart failure. Am J Cardiol 2009;103:1269-74.
    • (2009) Am J Cardiol , vol.103 , pp. 1269-1274
    • Tang, W.H.1    Katz, R.2    Brennan, M.L.3    Aviles, R.J.4    Tracy, R.P.5    Psaty, B.M.6
  • 46
    • 58149263078 scopus 로고    scopus 로고
    • Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea
    • Shah KB, Kop WJ, Christenson RH, Diercks DB, Kuo D, Henderson S, et al. Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea. Clin Chem 2009;55:59-67.
    • (2009) Clin Chem , vol.55 , pp. 59-67
    • Shah, K.B.1    Kop, W.J.2    Christenson, R.H.3    Diercks, D.B.4    Kuo, D.5    Henderson, S.6
  • 47
    • 79960596886 scopus 로고    scopus 로고
    • Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure
    • Zile MR, Desantis SM, Baicu CF, Stroud RE, Thompson SB, McClure CD, et al. Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure. Circ Heart Fail 2011;4:246-56.
    • (2011) Circ Heart Fail , vol.4 , pp. 246-256
    • Zile, M.R.1    Desantis, S.M.2    Baicu, C.F.3    Stroud, R.E.4    Thompson, S.B.5    McClure, C.D.6
  • 49
    • 77953109129 scopus 로고    scopus 로고
    • Serum markers of collagen turnover predict future shocks in implantable cardioverter-defibrillator recipients with dilated cardiomyopathy on optimal treatment
    • Kanoupakis EM, Manios EG, Kallergis EM, Mavrakis HE, Goudis CA, Saloustros IG, et al. Serum markers of collagen turnover predict future shocks in implantable cardioverter-defibrillator recipients with dilated cardiomyopathy on optimal treatment. J Am Coll Cardiol 2010;55:2753-9.
    • (2010) J Am Coll Cardiol , vol.55 , pp. 2753-2759
    • Kanoupakis, E.M.1    Manios, E.G.2    Kallergis, E.M.3    Mavrakis, H.E.4    Goudis, C.A.5    Saloustros, I.G.6
  • 50
    • 0034727695 scopus 로고    scopus 로고
    • Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES)
    • Rales Investigators
    • Zannad F, Alla F, Dousset B, Perez A, Pitt B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation 2000;102:2700-6.
    • (2000) Circulation , vol.102 , pp. 2700-2706
    • Zannad, F.1    Alla, F.2    Dousset, B.3    Perez, A.4    Pitt, B.5
  • 51
    • 77649187120 scopus 로고    scopus 로고
    • Circulating matrix metalloproteinase-3 and metalloproteinase-9 and tissue Doppler measures of diastolic dysfunction to risk stratify patients with systolic heart failure
    • Buralli S, Dini FL, Ballo P, Conti U, Fontanive P, Duranti E, et al. Circulating matrix metalloproteinase-3 and metalloproteinase-9 and tissue Doppler measures of diastolic dysfunction to risk stratify patients with systolic heart failure. Am J Cardiol 2010;105:853-6.
    • (2010) Am J Cardiol , vol.105 , pp. 853-856
    • Buralli, S.1    Dini, F.L.2    Ballo, P.3    Conti, U.4    Fontanive, P.5    Duranti, E.6
  • 52
    • 41449108661 scopus 로고    scopus 로고
    • Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: An independent predictor of mortality
    • Frantz S, Stork S, Michels K, Eigenthaler M, Ertl G, Bauersachs J, et al. Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: an independent predictor of mortality. Eur J Heart Fail 2008;10:388-95.
    • (2008) Eur J Heart Fail , vol.10 , pp. 388-395
    • Frantz, S.1    Stork, S.2    Michels, K.3    Eigenthaler, M.4    Ertl, G.5    Bauersachs, J.6
  • 54
    • 70349975735 scopus 로고    scopus 로고
    • The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients
    • Lin YH, Lin LY, Wu YW, Chien KL, Lee CM, Hsu RB, et al. The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients. Clin Chim Acta 2009;409:96-9.
    • (2009) Clin Chim Acta , vol.409 , pp. 96-99
    • Lin, Y.H.1    Lin, L.Y.2    Wu, Y.W.3    Chien, K.L.4    Lee, C.M.5    Hsu, R.B.6
  • 56
    • 77954658143 scopus 로고    scopus 로고
    • Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: Data from the DEAL-HF study
    • Lok DJ, Van Der Meer P, de la Porte PW, Lipsic E, Van Wijngaarden J, Hillege HL, et al. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin Res Cardiol 2010;99:323-8.
    • (2010) Clin Res Cardiol , vol.99 , pp. 323-328
    • Lok, D.J.1    Van Der Meer, P.2    De La Porte, P.W.3    Lipsic, E.4    Van Wijngaarden, J.5    Hillege, H.L.6
  • 57
    • 0030444643 scopus 로고    scopus 로고
    • The endothelin system and its potential as a therapeutic target in cardiovascular disease
    • DOI 10.1016/S0163-7258(96)00101-5, PII S0163725896001015
    • Gray GA, Webb DJ. The endothelin system and its potential as a therapeutic target in cardiovascular disease. Pharmacol Ther 1996;72:109-48. (Pubitemid 26423301)
    • (1996) Pharmacology and Therapeutics , vol.72 , Issue.2 , pp. 109-148
    • Gray, G.A.1    Webb, D.J.2
  • 59
    • 77955516734 scopus 로고    scopus 로고
    • Clinical significance of endogenous vasoactive neurohormones in chronic systolic heart failure
    • Tang WH, Shrestha K, Martin MG, Borowski AG, Jasper S, Yandle TG, et al. Clinical significance of endogenous vasoactive neurohormones in chronic systolic heart failure. J Card Fail 2010;16:635-40.
    • (2010) J Card Fail , vol.16 , pp. 635-640
    • Tang, W.H.1    Shrestha, K.2    Martin, M.G.3    Borowski, A.G.4    Jasper, S.5    Yandle, T.G.6
  • 60
    • 0036774973 scopus 로고    scopus 로고
    • Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?
    • DOI 10.1016/S0167-5273(02)00182-1, PII S0167527302001821
    • Kalra PR, Moon JC, Coats AJ. Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure? Int J Cardiol 2002;85:195-7. (Pubitemid 35245980)
    • (2002) International Journal of Cardiology , vol.85 , Issue.2-3 , pp. 195-197
    • Kalra, P.R.1    Moon, J.C.C.2    Coats, A.J.S.3
  • 62
    • 26444587528 scopus 로고    scopus 로고
    • Four-day urocortin-I administration has sustained beneficial haemodynamic, hormonal, and renal effects in experimental heart failure
    • DOI 10.1093/eurheartj/ehi351
    • Rademaker MT, Charles CJ, Espiner EA, Frampton CM, Lainchbury JG, Richards AM. Four-day urocortin-I administration has sustained beneficial haemodynamic, hormonal, and renal effects in experimental heart failure. Eur Heart J 2005;26:2055-62. (Pubitemid 41435727)
    • (2005) European Heart Journal , vol.26 , Issue.19 , pp. 2055-2062
    • Rademaker, M.T.1    Charles, C.J.2    Espiner, E.A.3    Frampton, C.M.4    Lainchbury, J.G.5    Richards, A.M.6
  • 64
  • 65
    • 17444382670 scopus 로고    scopus 로고
    • Neurohormonal activation in congestive heart failure and the role of vasopressin
    • DOI 10.1016/j.amjcard.2005.03.003, Hyponatemia in Congestive Heart Failure
    • Chatterjee K. Neurohormonal activation in congestive heart failure and the role of vasopressin. Am J Cardiol. 2005;95:8B-13B. (Pubitemid 40545927)
    • (2005) American Journal of Cardiology , vol.95 , Issue.9 SUPPL. 1
    • Chatterjee, K.1
  • 66
    • 77954755974 scopus 로고    scopus 로고
    • Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: Results from the International Collaborative of NT-proBNP Study
    • Mohammed AA, van Kimmenade RR, Richards M, Bayes-Genis A, Pinto Y, Moore SA, et al. Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from the International Collaborative of NT-proBNP Study. Circ Heart Fail 2010;3:354-61.
    • (2010) Circ Heart Fail , vol.3 , pp. 354-361
    • Mohammed, A.A.1    Van Kimmenade, R.R.2    Richards, M.3    Bayes-Genis, A.4    Pinto, Y.5    Moore, S.A.6
  • 67
    • 29744438811 scopus 로고    scopus 로고
    • Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin
    • DOI 10.1373/clinchem.2005.060038
    • Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006;52:112-9. (Pubitemid 43032474)
    • (2006) Clinical Chemistry , vol.52 , Issue.1 , pp. 112-119
    • Morgenthaler, N.G.1    Struck, J.2    Alonso, C.3    Bergmann, A.4
  • 68
    • 79957521352 scopus 로고    scopus 로고
    • Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure
    • Alehagen U, Dahlstrom U, Rehfeld JF, Goetze JP. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure. JAMA 2011;305:2088-95.
    • (2011) JAMA , vol.305 , pp. 2088-2095
    • Alehagen, U.1    Dahlstrom, U.2    Rehfeld, J.F.3    Goetze, J.P.4
  • 69
    • 63449090676 scopus 로고    scopus 로고
    • AVP receptor antagonists in patients with CHF
    • Kumar SK, Mather PJ. AVP receptor antagonists in patients with CHF. Heart Fail Rev 2009;14(2):83-6.
    • (2009) Heart Fail Rev , vol.14 , Issue.2 , pp. 83-86
    • Kumar, S.K.1    Mather, P.J.2
  • 70
    • 79955926423 scopus 로고    scopus 로고
    • Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction
    • Klip IT, Voors AA, Anker SD, Hillege HL, Struck J, Squire I, et al. Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction. Heart 2011;97:892-8.
    • (2011) Heart , vol.97 , pp. 892-898
    • Klip, I.T.1    Voors, A.A.2    Anker, S.D.3    Hillege, H.L.4    Struck, J.5    Squire, I.6
  • 72
    • 34248176428 scopus 로고    scopus 로고
    • Hemoglobin and N-terminal pro-brain natriuretic peptide: Independent and synergistic predictors of mortality in patients with acute heart failure. Results from the International Collaborative of NT-proBNP (ICON) Study
    • DOI 10.1016/j.cca.2007.03.010, PII S0009898107001416
    • Baggish AL, van Kimmenade R, Bayes-Genis A, Davis M, Lainchbury JG, Frampton C, et al. Hemoglobin and N-terminal pro-brain natriuretic peptide: independent and synergistic predictors of mortality in patients with acute heart failure. Results from the International Collaborative of NT-proBNP (ICON) Study. Clin Chim Acta 2007;381:145-50. (Pubitemid 46719148)
    • (2007) Clinica Chimica Acta , vol.381 , Issue.2 , pp. 145-150
    • Baggish, A.L.1    Van Kimmenade, R.2    Bayes-Genis, A.3    Davis, M.4    Lainchbury, J.G.5    Frampton, C.6    Pinto, Y.7    Richards, M.A.8    Januzzi, J.L.9
  • 74
    • 38049148378 scopus 로고    scopus 로고
    • Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease
    • Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008;117:163-8.
    • (2008) Circulation , vol.117 , pp. 163-168
    • Tonelli, M.1    Sacks, F.2    Arnold, M.3    Moye, L.4    Davis, B.5    Pfeffer, M.6
  • 76
    • 79953206194 scopus 로고    scopus 로고
    • Free and easy? Red cell distribution width (RDW) and prognosis in cardiac disease
    • Means RT Jr. Free and easy? Red cell distribution width (RDW) and prognosis in cardiac disease. J Card Fail 2011;17:299-300.
    • (2011) J Card Fail , vol.17 , pp. 299-300
    • Means Jr., R.T.1
  • 77
    • 77549085145 scopus 로고    scopus 로고
    • Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure
    • Allen LA, Felker GM, Mehra MR, Chiong JR, Dunlap SH, Ghali JK, et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail 2010;16:230-8.
    • (2010) J Card Fail , vol.16 , pp. 230-238
    • Allen, L.A.1    Felker, G.M.2    Mehra, M.R.3    Chiong, J.R.4    Dunlap, S.H.5    Ghali, J.K.6
  • 78
    • 85009068658 scopus 로고
    • The function of the kidneys in patients suffering from chronic cardiac disease without signs of heart failure
    • Stewart H, McIntosh JF. The function of the kidneys in patients suffering from chronic cardiac disease without signs of heart failure. J Clin Invest 1928;6:325-45.
    • (1928) J Clin Invest , vol.6 , pp. 325-345
    • Stewart, H.1    McIntosh, J.F.2
  • 79
    • 0034564507 scopus 로고    scopus 로고
    • Cystatin C-properties and use as diagnostic marker
    • Grubb AO. Cystatin C-properties and use as diagnostic marker. Adv Clin Chem 2000;35:63-99.
    • (2000) Adv Clin Chem , vol.35 , pp. 63-99
    • Grubb, A.O.1
  • 83
    • 66249141980 scopus 로고    scopus 로고
    • Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure
    • Yndestad A, Landro L, Ueland T, Dahl CP, Flo TH, Vinge LE, et al. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur Heart J 2009;30:1229-36.
    • (2009) Eur Heart J , vol.30 , pp. 1229-1236
    • Yndestad, A.1    Landro, L.2    Ueland, T.3    Dahl, C.P.4    Flo, T.H.5    Vinge, L.E.6
  • 84
    • 79957821843 scopus 로고    scopus 로고
    • Renal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failure
    • Shrestha K, Borowski AG, Troughton RW, Thomas JD, Klein AL, Tang WH. Renal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failure. J Card Fail 2011;17:472-8.
    • (2011) J Card Fail , vol.17 , pp. 472-478
    • Shrestha, K.1    Borowski, A.G.2    Troughton, R.W.3    Thomas, J.D.4    Klein, A.L.5    Tang, W.H.6
  • 85
    • 77955447813 scopus 로고    scopus 로고
    • Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate
    • Damman K, Van Veldhuisen DJ, Navis G, Vaidya VS, Smilde TD, Westenbrink BD, et al. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 2010;96:1297-302.
    • (2010) Heart , vol.96 , pp. 1297-1302
    • Damman, K.1    Van Veldhuisen, D.J.2    Navis, G.3    Vaidya, V.S.4    Smilde, T.D.5    Westenbrink, B.D.6
  • 87
    • 79957570488 scopus 로고    scopus 로고
    • Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function
    • Damman K, Ng Kam Chuen MJ, MacFadyen RJ, Lip GY, Gaze D, Collinson PO, et al. Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function. J Am Coll Cardiol 2011;57:2233-41.
    • (2011) J Am Coll Cardiol , vol.57 , pp. 2233-2241
    • Damman, K.1    Ng Kam Chuen, M.J.2    MacFadyen, R.J.3    Lip, G.Y.4    Gaze, D.5    Collinson, P.O.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.